Bio-identical Hormone & Peptide Specialists

Table of Contents
Cardio Res-Q Assessment from $775

Advanced labs, the Cleveland Heart panel and Dr. Varano’s evaluation:

Sleep Apnea and Heart Risk: Blood Pressure, AFib and What CPAP Trials Showed

Sleep Apnea and Heart Risk: Blood Pressure, AFib and What CPAP Trials Showed

Obstructive sleep apnea is closely linked to high blood pressure, atrial fibrillation, heart failure and stroke. It is very common in people who already have heart disease and often goes undiagnosed.

What treatment does for the heart is a separate question, and the answer is more limited than many people assume. CPAP reliably improves sleepiness and quality of life and lowers blood pressure a little in people whose pressure is uncontrolled. Large trials have not shown that it prevents heart attacks or strokes.

Key takeaways

  • Sleep apnea is common in midlife and far more common among people with high blood pressure, atrial fibrillation or heart failure.
  • The more severe the apnea, the higher the odds of developing high blood pressure in the following years.
  • In the largest randomized trial, CPAP did not reduce cardiovascular events, though it improved symptoms and quality of life.
  • Pooled trial data hint at benefit in people who use CPAP at least four hours a night, but that finding is not proof.
  • Treating sleep apnea does not replace managing blood pressure, cholesterol and blood sugar.

What sleep apnea is and how common it is

In obstructive sleep apnea the upper airway narrows or closes repeatedly during sleep. Each episode briefly lowers blood oxygen, triggers a surge from the nervous system and breaks up sleep. Severity is measured by the apnea-hypopnea index, or AHI: the number of these events per hour.

A 2021 scientific statement from the American Heart Association estimates that about 34% of middle-aged men and 17% of middle-aged women meet the criteria for obstructive sleep apnea.1 Among people with high blood pressure, heart failure, coronary artery disease, atrial fibrillation or stroke, the figure is as high as 40% to 80%.1

The same statement says sleep apnea is often underrecognized and undertreated in cardiovascular care. It is also more common with excess weight, a topic covered in our guide to visceral fat and heart risk.

The link to blood pressure

Blood pressure is the best documented connection. The Wisconsin Sleep Cohort Study measured breathing during sleep in 709 adults and checked their blood pressure four years later.

Compared with people who had no breathing events, those with an AHI of 5 to 14.9 had about twice the odds of high blood pressure at follow-up, and those with an AHI of 15 or more had nearly three times the odds.2 The result held after adjusting for body size, age, sex, alcohol and smoking.

That stepwise pattern, with more apnea followed by more hypertension, is why researchers regard sleep apnea as a likely cause of high blood pressure and not just a companion to it.

Heart rhythm and other heart conditions

A 2022 American Heart Association statement on sleep-disordered breathing and arrhythmias concluded that strong evidence implicates it in abnormal heart rhythms, including atrial fibrillation.

The statement is careful about treatment. Observational studies suggest that treating sleep apnea reduces the return of atrial fibrillation after a rhythm procedure, but high-level evidence from clinical trials is not available.3

For this reason the 2021 statement recommends screening for sleep apnea in people with resistant or poorly controlled high blood pressure and in people whose atrial fibrillation returns after cardioversion or ablation.1

What CPAP trials did and did not show

CPAP, or continuous positive airway pressure, keeps the airway open with gentle air pressure through a mask. Because sleep apnea is tied to so many heart problems, researchers expected that treating it would prevent them. The largest test of that idea was the SAVE trial.

SAVE enrolled 2,717 adults aged 45 to 75 who had moderate-to-severe obstructive sleep apnea and established coronary or cerebrovascular disease. They were randomly assigned to CPAP plus usual care or to usual care alone. After an average of 3.7 years, a serious cardiovascular event had occurred in 17.0% of the CPAP group and 15.4% of the usual-care group, a difference that was not statistically significant.4

CPAP did work on other measures. It significantly reduced snoring and daytime sleepiness and improved health-related quality of life and mood.4

Two features of the trial are worth knowing. Participants used CPAP for an average of 3.3 hours a night, and all of them already had cardiovascular disease, so the trial does not tell us about preventing a first event.

A 2023 analysis combined individual data from SAVE and two similar trials, 4,186 participants in all. Overall, CPAP again made no difference to repeat cardiovascular events. In a separate analysis of people who used CPAP at least four hours a day, good adherence was associated with a 31% lower risk.5 People who use CPAP faithfully may differ in other ways, so this result suggests a possibility and does not settle it.

On blood pressure, a pooled analysis of 36 trials with 9,434 patients found that CPAP lowered systolic pressure by about 2.6 mmHg in people whose blood pressure was uncontrolled at the start, and not at all in those whose pressure was already controlled.6

What gets checked

  • Symptoms. Loud snoring, pauses in breathing noticed by a partner, waking unrefreshed and daytime sleepiness are the usual clues.
  • A sleep study. Diagnosis requires overnight measurement of breathing, at home or in a sleep lab.
  • Blood pressure, including readings that stay high despite treatment. This is one of the situations where guidelines advise looking for sleep apnea.
  • Heart rhythm. Atrial fibrillation that keeps returning is another.
  • The standard risk factors. Cholesterol, blood sugar and waist size are assessed as they would be for anyone.

Decisions about treating sleep apnea belong with a sleep clinician. Symptoms, safety and quality of life are established reasons to treat, whatever the effect on heart events turns out to be.

Your next step

If you snore heavily, wake unrefreshed or have blood pressure that is hard to control, tell your doctor and ask whether a sleep study makes sense. For the wider picture on rest and the heart, see our guide to sleep and heart disease, and for how risk is measured overall, our guide to a heart disease risk assessment.

You can also answer the three quick questions in the screener on the Cardio Res-Q program page. Poor sleep is among the risk factors listed on that page. If you want to know whether sleep testing can be arranged, ask our team.

Cardiovascular Risk Screener

Are You a Candidate for Cardio Res-Q?

Three quick questions about the risk factors we screen for. Your answers stay between you and the clinic.

Frequently asked questions

Does CPAP prevent heart attacks and strokes?

Randomized trials have not shown that it does. In the largest trial, people with sleep apnea and existing cardiovascular disease had similar rates of events with or without CPAP over nearly four years. CPAP did improve sleepiness, snoring, mood and quality of life, which are valid reasons to use it.

Can sleep apnea cause high blood pressure?

The evidence points that way. In a study that measured sleep breathing and then followed people for four years, the odds of developing high blood pressure rose in step with the severity of apnea, independent of weight and other factors. CPAP lowers blood pressure modestly in people whose pressure is not controlled.

I do not feel sleepy during the day. Could I still have sleep apnea?

Yes. Most participants in the largest CPAP trial had moderate-to-severe sleep apnea with minimal sleepiness. Snoring, witnessed pauses in breathing and blood pressure that resists treatment are reasons to ask about testing even if you feel alert.

Related reading

This article is for general education and is not medical advice. Decisions about testing and medication should be made with your clinician. If you have chest pain or other symptoms of a heart attack, call 911.

Optimize Your Health Today!

Cardio Res-Q starts with the $775 Comprehensive or $999 Enhanced Assessment, led by Dr. Varano.

age management doctor philadelphia
Send Us A Message
About Dr. Kenneth Varano, D.O.
age management doctor philadelphia

YoungerMeMD is a physician-led practice in Anti-Aging, Functional and Preventive Medicine, and your care is delivered by our whole clinical team. That team works under Medical Director Kenneth Varano, D.O., who brings over 30 years in clinical medicine and more than 20 years in age management and functional medicine — using science-backed, patient-focused strategies that restore balance, vitality, and health longevity.

About Barbara Dougherty
anti aging treatments

Barbara Dougherty, MSN, CRNP, is a Board-Certified Family Nurse Practitioner and Certified Menopause Practitioner (MSCP) specializing in optimizing hormones, and improving cardio-metabolic health. 

Read Our Reviews

“I’ve been seeing Dr. Varano for just over a year now, and I don’t think I’ve been this healthy and energetic since grade school.

Transform Your Health Today

Ready to take the first step toward renewed energy, balance, and longevity? New patients can register for an initial evaluation to begin their personalized anti-aging journey with YoungerMe MD. Live Younger. Better. Longer. — with YoungerMe MD.

References

  1. Yeghiazarians Y, et al. Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation 2021. PMID 34148375 · doi:10.1161/CIR.0000000000000988↩
  2. Peppard PE, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000. PMID 10805822 · doi:10.1056/NEJM200005113421901↩
  3. Mehra R, et al. Sleep-Disordered Breathing and Cardiac Arrhythmias in Adults: Mechanistic Insights and Clinical Implications: A Scientific Statement From the American Heart Association. Circulation 2022. PMID 35912643 · doi:10.1161/CIR.0000000000001082↩
  4. McEvoy RD, et al. CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea. N Engl J Med 2016. PMID 27571048 · doi:10.1056/NEJMoa1606599↩
  5. Sánchez-de-la-Torre M, et al. Adherence to CPAP Treatment and the Risk of Recurrent Cardiovascular Events: A Meta-Analysis. JAMA 2023. PMID 37787793 · doi:10.1001/jama.2023.17465↩
  6. Pengo MF, et al. Effect of CPAP therapy on blood pressure in patients with obstructive sleep apnoea: a worldwide individual patient data meta-analysis. Eur Respir J 2025. PMID 39401854 · doi:10.1183/13993003.00837-2024↩
Book a Discovery Call Peptide Consult
Close
Book a Discovery Call
Close
Peptide Consult







    Transform Your
    Health & Wellness

    Fill up the form below to get started

      Provocation agent administered prior to timed urine collection (<6hr). Reveals toxic metal burden that can block hormone and peptide response.

      Identifies gluten sensitivity, intestinal permeability (leaky gut), and wheat-related immune reactivity – distinct from standard celiac testing.

      DNA Based stool test detecting pathogens, bacterial imbalances, parasites, and digestive markers – a comprehensive gut microbiome assessment.

      Non-invasive carotid artery ultrasound measuring arterial wall thickness – a direct look at your cardiovascular age.

      Cardio Res-Q cardiac risk panel – inflammation markers and cardiovascular biomarkers beyond standard labs.

      Evaluates intracellular vitamin, mineral, and antioxidant status – foundational to optimizing cellular health and peptide efficacy.

      Full Sex hormone, thyroid and adrenal picture. Identifies imbalances that affect energy, recovery, cognition, and peptide response.

      Advanced testing for immune reactions to wheat, gluten, and intestinal permeability.

      What It Evaluates

      Heavy metals like mercury, lead, cadmium, arsenic, and aluminum can cause:

      Conditions We Identify